What does this research mean for the field?

Genetic and pharmacogenetic testing are essential tools for identifying cardiovascular risk factors and enabling personalized therapeutic strategies, and should be recognized as a fundamental diagnostic branch in cardiology. Novelty: ClaimNovelty.SYNTHESIS. Consensus alignment: ConsensusAlignment.NEUTRAL.

September 30, 2019Open Access

The review highlights the increasing role of molecular genetics and pharmacogenetics in personalizing cardiovascular disease management, improving clinical outcomes, and reducing medical costs.

View Full Paper

Ask AI

Bookmark

Why the study?

Cardiovascular diseases are the leading cause of death worldwide, making the ability to accurately define individual susceptibility strategically important for tailored prevention and therapy.

Design

Review

Authors

GKGeraldo Krasi VPVincenza Precone SPStefano Paolacci

Discussion

Member takes

Overview

Supports exploring pharmacogenetic testing in select cardiovascular patients; leaves open prospective validation of outcome and cost benefits.

Structured PICO

Population

Patients with cardiovascular diseases

Intervention

Genetic testing and pharmacogenetics

Genetic and pharmacogenetic testing are emerging as crucial diagnostic tools in cardiology for personalized medicine.

Cite This Study

Krasi et al. (2019) studied this question.

synapsesocial.com/papers/6a1bcd4d1567d2fc4d5f07a6 https://doi.org/10.23750/abm.v90i10-s.8748

View Full Paper

Ask AI

Bookmark

September 30, 2019Open Access

The review highlights the increasing role of molecular genetics and pharmacogenetics in personalizing cardiovascular disease management, improving clinical outcomes, and reducing medical costs.

View Full Paper

Ask AI

Bookmark

Why the study?

Cardiovascular diseases are the leading cause of death worldwide, making the ability to accurately define individual susceptibility strategically important for tailored prevention and therapy.

Design

Review

Authors

GKGeraldo Krasi VPVincenza Precone SPStefano Paolacci

Discussion

Member takes

Overview

Supports exploring pharmacogenetic testing in select cardiovascular patients; leaves open prospective validation of outcome and cost benefits.

Structured PICO

Population

Patients with cardiovascular diseases

Intervention

Genetic testing and pharmacogenetics

Genetic and pharmacogenetic testing are emerging as crucial diagnostic tools in cardiology for personalized medicine.

Cite This Study

Krasi et al. (2019) studied this question.

synapsesocial.com/papers/6a1bcd4d1567d2fc4d5f07a6 https://doi.org/10.23750/abm.v90i10-s.8748

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark